Relationships between uptake of [68Ga]Ga-DOTA-TATE and absorbed dose in [177Lu]Lu-DOTA-TATE therapy

EJNMMI Research

Original Research

Anna Sundlöv¹  Katarina Sjögreen Gleisner²  Daniel Roth²  Johan Gustafsson²  Cecilia Hindorf³  Anna Stenvall⁴  Lena Jönsson⁴  Tomas Ohlsson⁵  Erik Larsson⁵ 

[1] Division of Oncology, Department of Clinical Sciences, Lund, Lund University, Lund, Sweden;Medical Radiation Physics, Lund, Lund University, Lund, Sweden;Medical Radiation Physics, Lund, Lund University, Lund, Sweden;Department of Radiation Physics and Nuclear Medicine, Karolinska University Hospital, Stockholm, Sweden;Medical Radiation Physics, Lund, Lund University, Lund, Sweden;Radiation Physics, Skåne University Hospital, Lund, Sweden;Radiation Physics, Skåne University Hospital, Lund, Sweden;

关键词: Radionuclide therapy;    Dosimetry;    Neuroendocrine tumours;    Peptide receptor radionuclide therapy;    Somatostatin receptor imaging;    DOTA-TATE;    Ga PET;    Lu SPECT;   

DOI  :  10.1186/s13550-022-00947-2

 received in 2022-09-05, accepted in 2022-12-06,  发布年份 2022

来源: Springer

【 授权许可】

CC BY   
© The Author(s) 2022

【 图 表 】

Fig. 2

Fig. 1

Fig. 6

Fig. 4

Fig. 1

Fig. 1

Fig. 4

Fig. 1

Fig. 7

40708_2022_178_Article_IEq42.gif

Fig. 3

Fig. 6

40708_2022_178_Article_IEq39.gif

Fig. 6

Fig. 2

40708_2022_178_Article_IEq35.gif

40517_2022_243_Article_IEq20.gif

40517_2022_243_Article_IEq19.gif

Fig. 1

Fig. 4

Fig. 2

Fig. 3

40708_2022_178_Article_IEq25.gif

Fig. 2

Fig. 3

40517_2022_243_Article_IEq17.gif

40517_2022_243_Article_IEq16.gif

Fig. 2

Fig. 1

40708_2022_178_Article_IEq17.gif

Fig. 3

Fig. 5

Fig. 1

40517_2022_243_Article_IEq14.gif

Fig. 2

Fig. 1

Fig. 4

Fig. 2

Fig. 2

40517_2022_243_Article_IEq1.gif